A detailed history of Citigroup Inc transactions in In Mode Ltd. stock. As of the latest transaction made, Citigroup Inc holds 73,519 shares of INMD stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,519
Previous 38,692 90.01%
Holding current value
$1.27 Million
Previous $705,000 76.31%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.43 - $19.06 $537,380 - $663,802
34,827 Added 90.01%
73,519 $1.24 Million
Q2 2024

Aug 12, 2024

SELL
$17.02 - $21.0 $557,251 - $687,561
-32,741 Reduced 45.83%
38,692 $705,000
Q1 2024

May 10, 2024

SELL
$20.45 - $26.49 $488,223 - $632,422
-23,874 Reduced 25.05%
71,433 $1.54 Million
Q4 2023

Feb 09, 2024

BUY
$19.02 - $30.13 $608,164 - $963,406
31,975 Added 50.49%
95,307 $2.12 Million
Q3 2023

Nov 09, 2023

BUY
$30.46 - $46.04 $29,698 - $44,889
975 Added 1.56%
63,332 $1.93 Million
Q2 2023

Aug 10, 2023

BUY
$31.57 - $37.73 $682,196 - $815,307
21,609 Added 53.03%
62,357 $2.33 Million
Q1 2023

May 11, 2023

SELL
$29.72 - $41.45 $120,930 - $168,660
-4,069 Reduced 9.08%
40,748 $1.3 Million
Q4 2022

Feb 09, 2023

BUY
$30.23 - $38.71 $41,082 - $52,606
1,359 Added 3.13%
44,817 $1.6 Million
Q3 2022

Nov 10, 2022

BUY
$22.51 - $38.27 $564,258 - $959,314
25,067 Added 136.3%
43,458 $1.27 Million
Q2 2022

Aug 10, 2022

SELL
$20.97 - $37.47 $1.42 Million - $2.54 Million
-67,866 Reduced 78.68%
18,391 $412,000
Q1 2022

May 12, 2022

SELL
$34.38 - $65.77 $15,505 - $29,662
-451 Reduced 0.52%
86,257 $3.18 Million
Q4 2021

Feb 10, 2022

BUY
$63.78 - $97.86 $3.15 Million - $4.84 Million
49,428 Added 132.59%
86,708 $6.12 Million
Q3 2021

Nov 10, 2021

BUY
$45.58 - $88.24 $1.7 Million - $3.29 Million
37,280 New
37,280 $5.95 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.44B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.